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ABSTRACT It hasbeenshown that thepropensity of a protein to formamyloid-like ﬁbrils canbepredictedwith highaccuracy from
the knowledge of its amino acid sequence. It has also been suggested, however, that some regions of the sequences are more
important than others in determining the aggregation process. Here, we have addressed this issue by constructing a set of
‘‘sequence scrambled’’ variants of the ﬁrst 29 residues of horse heart apomyoglobin (apoMb1-29), in which the sequence was
modiﬁed while maintaining the same amino acid composition. The clustering of the most amyloidogenic residues in one region of
the sequencewas found to cause amarked increase of the elongation rate (kagg) and a remarkable shortening of the lagphase (tlag)
of the ﬁbril growth, as determined by far-UV circular dichroismand thioﬂavin T ﬂuorescence.Wealso show that taking explicitly into
consideration the presence of aggregation-promoting regions in the predictive methods results in a quantitative agreement
between the theoretical and observed kagg and tlag values of the apoMb1-29 variants. These results, together with a comparison
between homologous segments from the family of globins, indicate the existence of a negative selection against the clustering of
highly amyloidogenic residues in one or few regions of polypeptide sequences.
INTRODUCTION
It has been suggested that amyloid formation is a funda-
mental characteristic of the chemistry of polypeptide chains
(1,2). Most proteins, if not all, can form amyloid-like ﬁbrils
of particularly high thermodynamic stability under appro-
priate conditions (1). It is also increasingly recognized that,
from bacteria to humans, some proteins can form amyloid-
like ﬁbrils in vivo that fulﬁll a variety of biological functions
(2,3). Examples are the sequestration of melanin pigments in
mammals (3–5), the transfer of inheritable information in
fungal prion proteins (6), and the modulation of the activity
of a bactericide peptide from Klebsiella pneumoniae by its
own aggregation (7). Other proteins, which by contrast are
designed by evolution to remain soluble, form extracellular
amyloid ﬁbrils or intracellular inclusions with amyloid-like
characteristics following a failure to remain in such a soluble
state, and give rise to well-described pathological states (2).
These range from neurodegenerative conditions, such as
Alzheimer’s disease, Parkinson’s disease, and spongiform
encephalopathies, to systemic amyloidoses including light
chain amyloidosis or dialysis-related amyloidosis (2,8). The
considerable tendency of proteins to form amyloid-like ﬁbrils,
as well as the unique molecular organization of these well-
ordered and self-organized structures, has also led many in-
vestigators to explore the biotechnological applications of
these ﬁbrillar aggregates as nanomolecular materials (9,10).
The generic ability of polypeptide chains to aggregate into
morphologically similar amyloid-like ﬁbrils, regardless of
the structures and sequences of the precursor proteins, has sug-
gested that the underlying physicochemical principles behind
this process may be rationalized on relatively simple, uni-
versally valid grounds. It was ﬁrst shown that the effect of a
mutation on the aggregation rate of a peptide or protein in its
unfolded state is determined by the effect that such mutation
has on simple characteristics of the primary sequence, like
charge, hydrophobicity or propensity to form b-sheet structure
(11). Using these or related factors, predictive algorithms were
developed that are able to determine the change in the rate or
propensity of aggregation of an unstructured polypeptide
chain following mutation (11–15), the absolute aggregation
rate (16,17), or the most aggregation-prone regions within a
sequence (12,15,17–22). These algorithms can identify
‘‘amyloidogenic’’ or ‘‘aggregation-promoting’’ regions of
the sequence that overlap with satisfactory accuracy with
those sequence portions known to form, from experimental
results, the b-core of the ﬁbrils in a number of test cases. These
studies clearly show (and even provide a rational explanation)
that a limited portion of the sequence plays a key role in the
aggregation process and participates in the formation of the
b-core of the mature ﬁbrils (23–25). On the other hand, to a
ﬁrst approximation, the aggregation rate appears to correlate
to the average aggregation propensity of the polypeptide chain,
with no distinction between amyloidogenic and nonamyloi-
dogenic regions (13,16,17).
To investigate the importance of the regions of the se-
quence with a high aggregation propensity, as opposed to the
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entire sequence, in determining the aggregation behavior of
an unstructured polypeptide, we have used a peptide corre-
sponding to the ﬁrst 29 residues of horse heart apomyoglobin
(apoMb1-29). Full-length apoMb is a well-described system
that has been extensively used for folding as well as aggre-
gation studies (26–29); apoMb1-29 is an unstructured peptide
that is soluble at neutral pH, but self-assembles at pH 2.0 into
amyloid-like ﬁbrils that are morphologically, structurally, and
tinctorially indistinguishable from those formed by naturally
amyloidogenic proteins (30). The core of the ﬁbrils is formed
by the region of the sequence spanning from residue 7 to res-
idue 16 or 18, as probed by proteolysis studies (30).
We have designed four scrambled sequence variants of
apoMb1-29. These variants feature the same length and amino
acid composition as the wild-type peptide, but a scrambled
sequence resulting in a modiﬁed aggregation propensity
proﬁle along the sequence relative to the wild-type, as pre-
dicted by the algorithms mentioned above. We shall describe
that the clustering of the most amyloidogenic residues in one
region of the sequence, resulting into a wide and high peak in
the aggregation propensity proﬁle, leads to a marked change
in the kinetics of aggregation, with a reduction of the lag phase
by over 5000-fold and a 40-fold enhancement of the ﬁbril
elongation rate. We will also show that aggregation propen-
sity proﬁles of this type have clearly been negatively selected
by evolution in the structural family of globins, emphasizing
that prevention of aggregation has been an important driving
force in the evolution of natural amino acid sequences.
MATERIALS AND METHODS
Calculation of the intrinsic aggregation propensity
proﬁle of a sequence
Except for the aggregation propensity proﬁles reported in Fig. 1, B–D, all the
aggregation propensity proﬁles and the derived parameters were calculated
according to Pawar et al. (18). In brief, the intrinsic aggregation propensities
(pagg) of the 20 naturally occurring amino acid residues were taken from the
aforementioned work at pH 2.0 (also listed in the Supplementary Material,
Table S1). The pagg value of an individual amino acid along a sequence was
increased by apat Ipat if it belonged to a ﬁve-residue or longer sequence stretch
having a pattern of alternating polar and nonpolar residues (see Table S1 for
viewing which residues are considered polar and nonpolar, respectively). As
in the previous work apat and Ipat values were set equal to 0.39 and 1, respec-
tively (18). We then considered:
P
agg
i ¼
1
7
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3
j¼3
p
agg
i1 j; (1)
where paggi1j is the p
agg value of the individual amino acid at position i 1 j
(with j varying from 3 to 13). With this deﬁnition Paggi is the intrinsic
aggregation propensity of a seven-residue window centered at position i and
resulting from the average of the pagg values of its seven residues. The Paggi
values were not calculated for the ﬁrst three residues at the N-terminus and
the last three residues at the C-terminus, due to the chosen window of seven
residues.
To deﬁne a proﬁle of intrinsic aggregation propensity along the sequence
we generated randomly Ns sequences of length N using the natural occur-
rences of the 20 amino acids (reported in Table S1) as their actual proba-
bilities in the random procedure. The average (magg) and standard deviation
(sagg) of the P
agg
i values within the Ns sequences were deﬁned as:
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where Sk is the sequence No. k (with k varying from 1 to Ns), N is the number
of residues in each sequence and Ns is the number of sequences. N and Ns
were set equal to 29 and 10,000 in this study, respectively. We then cal-
culated the intrinsic Z-score of aggregation of a seven-residue window
centered at position i (Zaggi ) using:
Z
agg
i ¼
P
agg
i  magg
sagg
: (4)
The plot of Zaggi versus residue number (from residue 4 to residue N  3)
represents the intrinsic aggregation propensity proﬁle (Zaggprof ), as reported
(18).
The aggregation propensity proﬁles in Fig. 1, B–D, were calculated
according to Sanchez de Groot et al. (19), Fernandez-Escamilla et al. (12),
and Tartaglia et al. (13), respectively. For the analysis in Fig. 1 C the fol-
lowing parameters were used: pH ¼ 2.0; T ¼ 310 K; ionic strength ¼ 0.01
M; triﬂuoroethanol concentration ¼ 0%; protein stability ¼ 3 kcal/mol
(12). The horizontal line corresponds to the threshold of signiﬁcance as
deﬁned by the authors. For the analysis in Fig. 1 D, the relative change of
aggregation rate considering a single-point mutation F/X was calculated
for each residue i of the apoMb1-29 variants. To allow the comparison be-
tween all plots reported in Fig. 1, A–D, a sliding window of seven residues
was used in all cases.
Calculation of the aggregation parameters of a
polypeptide chain (Pagg, Z agg, Sagg, Z agg0 )
The aggregation propensity (Pagg) and aggregation Z-score (Z agg) of a se-
quence of N residues were calculated as:
P
agg ¼ 1
N
+
N
i¼1
p
agg
i (5)
Z
agg ¼ P
agg  magg
sagg
: (6)
We deﬁne Sagg as the total surface of the aggregation propensity proﬁle
(Zaggprof ) that lies above a Z
agg
i threshold of 1. This was achieved using (G.-G.
Tartaglia and M. Vendruscolo, unpublished results):
S
agg ¼ +
N3
i¼4
Z
agg
i u1ðZaggi Þ; (7)
where u1(Z
agg
i ) is 1 for Z
agg
i $ 1 and 0 for Z
agg
i , 1. Since S
agg appears to be
an important determinant of aggregation rate, the Zagg values of a set of in-
trinsically disordered proteins were recalculated (Zagg0 ) using:
Z
agg
0 ¼
+
N3
i¼4
Z
agg
i uðZaggi Þ
+
N3
i¼4
u0ðZaggi Þ
; (8)
where u0(Z
agg
i ) is 1 for Z
agg
i $ 0 and 0 for Z
agg
i , 0. Z
agg
0 represents the
aggregation Z-score of a sequence resulting from the regions of the sequence
with a higher aggregation propensity. The Zagg0 values were analyzed with
the experimental aggregation rates in a multiple regression ﬁtting to determine
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newly optimized pagg as described (16). Finally the Zagg0 values of the
apoMb1-29 variants were determined using Eqs. 5, 6, and 8.
Fourier transform infrared spectroscopy
All the apoMb1-29 peptides were purchased from GenScript (Piscataway,
NJ). Each of the apoMb1-29 lyophilized peptides was dissolved in 50 mL of a
solution containing 10 mM HCl, pH 2.0, at a peptide concentration equal or
higher than 5 mg/ml, and incubated 1 week at room temperature. Spectra
were collected at room temperature using a Jasco FTIR-4200 spectrometer
(Tokyo, Japan). Sample aliquots were placed between CaF2 windows, sep-
arated by a 6-mM-thick spacer. The sample and detector compartments were
thoroughly purged with N2. Spectra represent averages of 200 scans re-
corded between 4000 and 400 cm1 at a resolution of 4 cm1. All spectra
were baseline corrected, blank subtracted, and smoothed using a means-
movement function.
Aggregation kinetics probed by far-ultraviolet
circular dichroism
Aggregation of wild-type and scrambled sequence apoMb1-29 variants was
initiated as previously described for the wild-type peptide (30). Brieﬂy, the
lyophilized peptides were dissolved in 10 mM Tris-HCl, pH 8.3, centrifuged
for 5 min at 16,000 rpm, and ﬁltered using 0.02 mMAnatop ﬁlters (Whatman,
Brentford, UK). The samples were then diluted to reach a peptide concen-
tration of 0.2 mg/ml, led to pH 2.0 adding a minimal amount of 2 M HCl,
and incubated at 37C. Far-UV CD spectra were acquired at regular time
intervals at 37C using a 1-mm pathlength cuvette and a Jasco J-810 spectro-
polarimeter. This was equipped with a thermostated cell holder connected to
a circulating Thermo Haake C25P water bath (Karlsruhe, Germany). Each
spectrum, recorded as the average of ﬁve scans, was blank subtracted and
smoothed using a fast Fourier transform ﬁlter. The residual ellipticity at 216
nm was plotted versus time. For the P4 apoMb1-29 variant, the resulting plot
was ﬁtted to the following single exponential function:
½u
t
¼ A expðkagg3 tÞ1 q; (9)
where A is the total change of mean residue ellipticity from time 0 toN, kagg
is the apparent aggregation rate constant, and q is the ﬁnal mean residue
ellipticity at timeN. For the wild-type, P1, P2, and P3 apoMb1-29 variants,
the plots were ﬁtted to the following empirical sigmoid function (31):
½ut ¼ A01
A
11 exp½ðt1=2  tÞkagg; (10)
where A and kagg have the same meaning as for Eq. 9, A0 is mean residue
ellipticity at time 0, and t1/2 is the midpoint of aggregation. The lag time of
aggregation, tlag, was determined from kagg and t1/2 as follows (31):
tlag ¼ t1=2  2
kagg
: (11)
Aggregation kinetics probed by
thioﬂavin T ﬂuorescence
The apoMb1-29 peptides were prepared and incubated as described above for
the CD measurements. At different incubation times aliquots of 60 ml were
mixed with 440 ml of 10 mM phosphate buffer, pH 6.0, containing 25 mM
ThT (Sigma-Aldrich, St. Louis, MO). The steady-state ﬂuorescence of the
resulting samples was measured at 25C using a 2 3 10-mm pathlength
cuvette and a Perkin-Elmer LS-55 ﬂuorimeter (Wellesley, MA) equipped
with a thermostated cell compartment attached to a Haake F8 water bath.
The excitation and emission wavelengths were 440 and 485 nm, respec-
tively. All measured ﬂuorescence values were blank subtracted and normal-
ized to the percentage of the maximum value. Plots of ﬂuorescence values
versus time were analyzed with a procedure of best ﬁt, using a single expo-
nential (Eq. 9) or a sigmoid (Eq. 10) function, as described above.
Construction of the peptide database from the
globin family
All sequences contained in the globin structural family of the Prosite data-
base (code PS01033) were aligned. Alignment was achieved using structural
criteria, which has been proposed to be a preferred method due to the ex-
tremely low sequence identity between some of the globin family members
(32). In practice, a multiple sequence alignment against a secondary struc-
ture pattern extracted from the three-dimensional structure of horse heart
FIGURE 1 Aggregation propensity proﬁles of
wild-type and scrambled sequence variants of
apoMb1-29. The aggregation propensity proﬁles
for panels A–D are calculated according to Pawar
et al. (18), Sanchez de Groot et al. (19), Fernandez-
Escamilla et al. (12), and Tartaglia et al. (13),
respectively. The proﬁles correspond to wild-type
(black), P1 (orange), P2 (green), P3 (red), and P4
(blue) apoMb1-29 variants. In panel C the P1 and P2
variants have aggregation propensity of 0 through-
out their sequences.
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myoglobin was performed using the ClustalW software. Only the sequence
fragments starting and ending at positions corresponding to the 1st and 29th
residues of apoMb1-29, respectively, and with a length comprised between
27 and 31 amino acids, were considered. The parameters Pagg, Zagg, and
Sagg were then calculated for all sequences from this data set as described
above (Eqs. 5–7).
RESULTS
Design of ‘‘scrambled sequence’’ variants
of apoMb1-29
As detailed in the Introduction section, several computational
methods have been developed to identify the regions of the
sequence, within an unstructured peptide or protein, with a
high potential to promote amyloid aggregation and form the
b-core of the resulting ﬁbrils. Using four of these programs,
the most amyloidogenic region of wild-type apoMb1-29 is
consistently predicted to be in all cases the central region of
the sequence, encompassing approximately residues 9–14
(Fig. 1). This prediction is in agreement with the experimental
data obtained with proteolysis showing that the region span-
ning approximately from residue 7 to residue 16 or 18 forms
the b-core of the ﬁbrils (30).
To assess the role of this central amyloidogenic region of the
sequence relative to the overall amino acid composition of
apoMb1-29, we designed four diverse variants of apoMb1-29
in which the sequence was scrambled with respect to the
wild-type sequence, i.e., it was changed while maintaining
the same length and amino acid composition. This reorga-
nization of the sequence was achieved by introducing mini-
mal changes, typically shifting some residues from the edge
regions of the sequence to the central portion. The sequences
of the designed ‘‘scrambled sequence’’ variants, named P1,
P2, P3, and P4 apoMb1-29, are reported in Table 1. Using the
terminology and parameter deﬁnition described in Materials
andMethods and previously reported (18), wild-type apoMb1-29
and the four designed variants have the same values of overall
aggregation score (termed Zagg, Table 1).
Despite their identical Zagg values, the apoMb1-29 variants
have different aggregation propensity proﬁles relative to the
wild-type peptide (Fig. 1). The prominence of the central
aggregation-promoting region above the critical threshold of
normalized aggregation propensity (Zaggi ¼ 1; see Materials
and Methods) is very different in the various cases, with
the P4 variant having the highest and largest peak (Fig. 1 A).
To have a quantitative measure of the prominence of the
aggregation-prone region, we introduced the Sagg parameter.
Sagg represents the total surface of the aggregation propensity
proﬁle that lies above the threshold Zaggi ¼ 1; and correlates
to both the height and width of the central aggregation-
promoting region (see Materials and Methods for details).
The Sagg parameter spans from a value of 0 for P1 to a value
of 7.74 for P4, the wild-type having an intermediate value of
0.59 (Table 1). Remarkably, the trend of prominence of the
aggregation-prone region predicted by Pawar et al. (18) for
the designed apoMb1-29 variants was conﬁrmed by three other
prediction methods, lending further support to the robustness
of the design (Fig. 1, B–D).
All apoMb1-29 variants form amyloid-like ﬁbrils
at low pH
As a ﬁrst step we established that the designed scrambled
sequence mutants do form amyloid-like ﬁbrils in vitro, as it
has been previously demonstrated for the wild-type peptide
(30). At pH 8.3 wild-type apoMb1-29 shows a far-UV CD
spectrum typical of largely unfolded polypeptide chains, with
a minimum at 200 nm (Fig. 2 A, dashed line). Similar far-
UV CD spectra were obtained at pH 8.3 for the scrambled se-
quence variants analyzed here (data not shown). Following
acidiﬁcation at pH 2.0, the far-UV CD spectra were initially
typical of an unfolded peptide (Fig. 2 A, dotted line). How-
ever, after 4 days at pH 2.0, all the apoMb1-29 variants had
spectra with a minimum mean residue ellipticity between 214
and 218 nm and a maximum between 195 and 199 nm, indi-
cating a high content of b-sheet structure (Fig. 2 A, solid lines).
When working with protein aggregates the obtained far-
UV CD spectra are likely to be affected by light scattering
phenomena, due to the large size of the aggregates and short
wavelength in the far-UV region of light. We therefore ana-
lyzed the apoMb1-29 variants using FTIR spectroscopy, which
is not signiﬁcantly affected by light scattering due to the long
wavelength that is used in this spectroscopic technique. The
FTIR spectra were recorded for three representative apoMb1-29
variants incubated at pH 2.0 for a few days, namely the
TABLE 1 Predicted parameters of apoMb1-29 aggregation
Variant Sequence Zagg* Saggy Zagg0
z
WT GLSDGEWQQVLNVWGKVEADIAGHGQEVL 0.37 0.59 0.625
P1 GLSDGEWQQVENVWGKVEADIAGHGQLVL 0.37 0.00 0.624
P2 GLSDGEWQQVLENVWGKVEADIAGHGQVL 0.37 0.32 0.607
P3 GLSDGEQQVLWINVWGKVEADAGHGQEVL 0.37 4.15 0.683
P4 GLSDGEQQVLVWIVNVWGKEADAGHGQEL 0.37 7.74 0.941
*Aggregation Z-score of the entire sequence, calculated as described in Materials and Methods, and previously (18).
yProminence of the aggregation promoting region, calculated as described in Materials and Methods.
zNew aggregation Z-score, calculated as described in Materials and Methods.
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wild-type, P1 and P4. The FTIR spectra presented an amide I
band with a maximum in the region 1620–1635 cm1, further
conﬁrming the presence of a largely b-sheet structure content
(Fig. 2 B). The differences in the far-UV CD and FTIR spec-
tra between the apoMb1-29 variants probably reﬂect the differ-
ences of sequence between them and consequently between
the structures of the resulting aggregates.
The addition of each aggregated peptide to a ThT solution
resulted in a signiﬁcant enhancement of the ﬂuorescence at
485 nm, with a ﬂuorescence signal at the equilibrium at least
40 times higher than the one at t ¼ 0 (Fig. 3 A). All these
spectroscopic properties obtained with far-UV CD, FTIR, and
ThT ﬂuorescence spectroscopies were shown to be associ-
ated with the formation of amyloid-like ﬁbrils for wild-type
apoMb1-29 (30). Therefore, we concluded that the four scram-
bled sequence variants formed amyloid-like ﬁbrils under the
conditions used here.
FIGURE 2 Far-UV CD and FTIR spectra of apoMb1-29 variants. (A) Far-
UV CD spectra. (B) FTIR spectra. The spectra refer to wild-type at pH 8.3
immediately after dissolution (black, dashed line), wild-type at pH 2.0
immediately after pH decrease (black, dotted line), wild-type at pH 2.0, and
t ¼ 4 days (black, solid line), P1 at pH 2.0 and t ¼ 4 days (orange), P2 at
pH 2.0 and t ¼ 4 days (green), P3 at pH 2.0 and t ¼ 4 days (red), and P4 at
pH 2.0 and t ¼ 4 days (blue).
FIGURE 3 Kinetics of aggregation for apoMb1-29 variants. (A) Aggrega-
tionwas followedbyThTﬂuorescence (excitation 440 nm, emission 485 nm).
(B) Aggregation was followed by far-UV CD at 216 nm. (C) Comparison of
ThT and far-UV CD kinetics of aggregation for three representative variants.
In all panels open symbols and solid lines refer to ThTﬂuorescence data; solid
symbols and dashed lines refer to CD data; the kinetic traces correspond to
wild-type (circles), P1 (inverted triangles), P2 (triangles), P3 (diamonds),
and P4 (squares) apoMb1-29 variants. In all cases the insets show the P4 traces
on an extended timescale. In all panels the lines through the data points of the
P4 variant represent the best ﬁts to a single exponential function (Eq. 9); the
lines through the data points of the wild-type, P1, P2, and P3 variants rep-
resent the best ﬁts to a sigmoid function (Eq. 10). The parameters calculated
for each variant from these analyses (kagg and tlag) are reported in Table 2.
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Differences in the aggregation kinetics of the
apoMb1-29 variants are determined by differences
in the Sagg values
We then followed the kinetics of aggregation of the apoMb1-29
variants by ThT ﬂuorescence and far-UV CD (Fig. 3, A–B).
The kinetic traces of P4 apoMb1-29 did not present any
detectable lag phase, but only a rapid exponential phase (Fig.
3, A–B, insets). These traces were analyzed with a procedure
of best ﬁt using a single exponential function (Eq. 9). By
contrast, the kinetic traces of wild-type and P1, P2, and P3
apoMb1-29 presented an important lag phase followed by an
exponential growth phase (Fig. 3, A–B). The data were
analyzed using a sigmoid function (Eq. 10). The rate constants
for the exponential phase (kagg) and the lengths of the lag
phase (tlag) obtained for all the variants are reported in Table 2.
The kinetic traces obtained for wild-type apoMb1-29, as well
as the resulting kagg and tlag values, are consistent with those
previously reported (30). For each variant, the kinetic traces
and the resulting kagg and tlag values obtained in independent
experiments and with the two different techniques (CD and
ThT ﬂuorescence) were highly coherent (Table 2; Fig. 3 C).
These results show that the various mutants have very
different values of tlag and kagg (Table 2) despite their identical
amino acid compositions and Zagg values (Table 1). To elu-
cidate the determinants of the observed differences in ag-
gregation time course and resulting kagg and tlag parameters,
we assessed whether the kinetic parameters of aggregation
correlated with the prominence of the aggregation-promoting
region (Sagg). A signiﬁcant linear correlation was found be-
tween kagg and S
agg (Fig. 4 A; r ¼ 0.96; p ¼ 0.01). Thus, the
differences in the Sagg values between the apoMb1-29 variants
seem to account for the differences between their aggregation
rates.
Sagg also correlates linearly to tlag, although the p-value lies
slightly above the statistical signiﬁcance threshold of 0.05 in
this case (Fig. 4 B; r ¼ 0.84; p ¼ 0.07). This correlation is
nevertheless satisfying, considering that the individual pagg
used to calculate Sagg were optimized on experimental kagg
data rather than tlag values (18). Moreover, it has been dem-
onstrated that the values of kagg and tlag are strictly correlated
for a number of variants of insulin, glucagon, and the 40-
residue form of the amyloid-b peptide (33), explaining why
both kagg and tlag correlate with S
agg. None of the other pa-
rameters tested, namely the width of the main aggregation-
promoting region on the proﬁle, its height, shape (width/
height), number of peaks, or Sagg normalized by the number of
peaks, gave any better correlation for either tlag or kagg (results
not shown).
Deﬁnition of an accurate predictor of aggregation
propensity for unstructured polypeptides
Having realized that the most amyloidogenic regions of the
sequence, which correspond to the highest values of the Zaggi
in the proﬁle, mostly determine the kinetic parameters of
TABLE 2 Measured parameters of apoMb1-29 aggregation
Variant tThTlag (h)* k
ThT
agg (h
1)* tCDlag (h)* k
CD
agg (h
1)*
WT 15 6 2 0.24 6 0.02 16.4 6 0.3 0.20 6 0.04
P1 29 6 6 0.20 6 0.01 24 6 6 0.28 6 0.01
P2 28.1 6 0.3 0.5 6 0.1 28.0 6 0.4 0.5 6 0.2
P3 20.7 6 0.2 0.64 6 0.07 21.3 6 0.3 1.2 6 0.4
P4 0y 10 6 1 0y 9 6 5
*Obtained from the analyses of the kinetic plots reported in Fig. 3, A and B.
The entries give the mean6 SE in two or three independent experiments, or
the value6 SE in the curve ﬁt (case of the ThT values of P3 and P4, and of
the CD values of WT and P4).
yLower than the experimental dead time (10 s).
FIGURE 4 Dependence of the kinetic parameters of aggregation on the
Sagg parameter. (A) Correlation between the natural logarithm of the rate
constant for the exponential phase (kagg) and S
agg. (B) Correlation between
the lag time of aggregation (tlag) and S
agg. Both panels report the mean6 SE
on both kagg and tlag, obtained after averaging the ThT ﬂuorescence and CD
data reported in Table 2.
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aggregation of an unstructured protein or peptide. a new
Z-score for aggregation was deﬁned, termed Zagg0 (G.-G.
Tartaglia and M. Vendruscolo, unpublished results). The
Zagg0 value of an unstructured polypeptide chain is calculated
from its sequence by considering only the Zaggi values that
appear to be sufﬁciently high in the proﬁle, after a new
optimization of the individual pagg (see Materials and
Methods for details). The Zagg0 values for all the apoMb1-29
variants studied here are reported in Table 1. Unlike the Zagg
values, the Zagg0 values are different among the apoMb1-29
variants, with the P4 mutant featuring the highest value. Both
the experimentally determined kagg and tlag values correlate
with Zagg0 providing statistically signiﬁcant r- and p-values
(r ¼ 0.96, p ¼ 0.01, and r ¼ 0.91, p ¼ 0.03, respectively).
Comparison with other peptides from the
structural family of globins
To evaluate the biological signiﬁcance of the observed aggre-
gation behavior of the apoMb1-29 variants analyzed here, we
compared their sequences and aggregation propensity pro-
ﬁles to those of the corresponding peptides from the struc-
tural family of globins. All known sequences of globins from
different organisms, including those of evolutionary distant
phyla such as eubacteria, were aligned. Following alignment,
the 745 sequence fragments corresponding to the sequence
of apoMb1-29 studied here were considered (see Materials
and Methods for details). The distributions of the Zagg and
Sagg values calculated over this database are shown in Fig. 5.
The apoMb1-29 variants studied in this work have Z
agg values
inside the interval mean 6 2 SD obtained from the overall
database (Fig. 5, inset). Wild-type, P1, and P2 apoMb1-29
also have ‘‘ordinary’’ Sagg values, i.e., in the interval mean6
2 SD (Fig. 5). On the contrary, both P3 and P4, particularly
the latter, have Sagg values signiﬁcantly higher than the mean
value of the dataset (higher than mean 6 2 SD; Fig. 5). The
P3 and P4 variants were designed without adding additional
residues with a high aggregation propensity, but simply by
scrambling the existing sequence of apoMb1-29. Thus it ap-
pears that the clustering of amino acids with high individual
propensities to aggregate in the center of the sequence, and
their resulting high kagg and low tlag values, represent an un-
usual situation within the structural family of globins.
DISCUSSION
The clustering of residues with high
amyloidogenic propensity promotes aggregation
Methods developed to predict the absolute aggregation rate
of a polypeptide chain and the change of rate following mu-
tation often consider the aggregation propensity of each resi-
due to be independent of its position along the sequence. As
a result, scrambled sequences are predicted to have similar
propensities and rates of aggregation as their wild-type coun-
terpart. However, aggregation appears to be driven by inter-
molecular interactions that take place between a limited set
of sequence regions (34–37). The question therefore arises as
to the importance of such regions in the determination of the
aggregation rate, and whether or not the residues involved
should be considered as partially dependent on the neigh-
boring residues.
In this work we have shown that ﬁve initially unstructured
peptides, sharing the same length and amino acid compo-
sition but with scrambled sequences, present very different
behaviors in terms of amyloid ﬁbril formation kinetics. The
lag times, corresponding to the rates of formation of oligo-
meric nuclei during the lag phase, span from,10 s (the dead
time in recording the aggregation trace of P4 apoMb1-29) to
30 h. Moreover, the rate constants of ﬁbril elongation differ
by almost 2 orders of magnitude. In particular, the clustering
of the most amyloidogenic residues within one region of the
sequence increases by ;40-fold the ﬁbril elongation rate,
and shortens the lag time below detectable levels (Table 2).
Scrambled variants of a sequence corresponding to the
N-terminal and middle regions of the Sup-35 prion were also
found to aggregate in vitro with different kinetics (38). In a
recent development of their algorithm that predicts amyloid
aggregation propensity, Ventura and colleagues deﬁned a
parameter that for each peak of the proﬁle measures the area
lying above a certain threshold (15). They noticed that half
of the sequence segments experimentally known to be in-
volved in aggregation correspond to the peaks of major area
within the various analyzed sequences (15). Simulation stud-
ies reinforced all these experimental results. A lattice-based
computer simulation showed an increasing propensity to
aggregate as the hydrophobic residues became concentrated in
FIGURE 5 Distribution of Sagg (main panel) and Zagg (inset) among the
structural family of globins. In both the major and inset ﬁgures the vertical
solid and dashed lines indicate the mean and mean 6 2 SD values, re-
spectively. The Sagg values for all the apoMb1-29 variants studied here are
shown with dotted vertical lines. The Zagg value for all apoMb1-29 variants
is 0.37 and falls within the mean 6 2 SD interval.
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fewer continuous subsequences (39). Using a toy model to
simulate the aggregation of unfolded polypeptides, the disper-
sion of critical residues was identiﬁed as a determinant of the
aggregation rate (40). Hence, the distribution of residues with
high amyloidogenic propensities within the sequence appears
to be an important determinant of aggregation kinetics, both
kagg and tlag.
How can we explain the increased aggregation rate con-
stants and decreased lag times observed when the most amy-
loidogenic residues are gathered within the sequence? The
correlations that we observe between Sagg and both kagg and
tlag suggest a possible rationalization at the molecular level.
During the lag phase, a series of thermodynamically unfa-
vorable oligomeric assemblies of increasing size are formed.
These oligomers become stable when they exceed the size of
the ‘‘critical nucleus’’, which depends on the speciﬁc sequence
and the conditions of the solution. Further addition of mono-
mers to the critical nucleus is then thermodynamically favor-
able (41). The clustering of the amino acids that are more
prone to aggregate, and thus that are thought to establish the
intermolecular interactions that drive aggregation, may create
the possibility of realizing critical nuclei of small size by in-
creasing the strength of intermolecular interactions. It could
also increase the probability of productive collisions of mono-
mers (lag phase) or of monomers or oligomers with a growing
ﬁbril (elongation phase), thus contributing to accelerate both
the lag and elongation phases, respectively (42).
The clustering of residues with high
amyloidogenic propensities is negatively selected
A number of proteins are intrinsically disordered, i.e., they
normally exist in an unstructured state unless they are bound
to their substrates or macromolecular targets (43). Even glob-
ular proteins, forming a compact folded state during most of
their lifetimes, can transiently adopt an unfolded state, par-
ticularly during biosynthesis, translocation, or stress condi-
tions. Thus, avoiding aggregation from an unstructured state
is generally an issue for natural proteins. If the clustering of
residues with high aggregation propensities is so deleterious,
one would expect it to be negatively selected by evolution.
Our analysis of the globin family clearly indicates that un-
balanced distributions of amyloidogenic residues, with a
resulting clustering of the most highly amyloidogenic ones
within one or few portions of the sequence (such as in P3 and
P4 apoMb1-29), has been selected against by natural evolu-
tion in the N-terminal trait of this structural family (Fig. 5).
P3 and P4 apoMb1-29 variants are artiﬁcially designed se-
quences, which are probably incompatible with the native
fold of the whole apoMb protein. However, aggregation pro-
ﬁles with shape and Sagg values comparable to those of P3
and P4 can be obtained with one or two single-point muta-
tions in the central region of the apoMb1-29 sequence, a situa-
tion that is more realistic from an evolutionary point of view
(data not shown). The fact remains that sequences with pro-
ﬁles and Sagg values similar to those of the P3 and P4 variants
are very rare, if not at all absent, indicating the existence of
a negative selection against such an unfavorable situation.
Hints of negative selection against long stretches of hy-
drophobic residues (44–46), patterns of alternating polar and
nonpolar residues (47), or stretches with very high aggrega-
tion propensity, calculated according to the TANGO algo-
rithm (48), have been observed on more extended databases.
All these results are highly consistent with our ﬁndings, as
hydrophobicity and patterns of alternating polar and nonpo-
lar residues contribute to the amyloidogenic propensity of
each amino acid (18). By constructing an artiﬁcial system in
which the only changed parameter was the dispersion of the
amino acid residues within a sequence, we provided an ex-
perimental conﬁrmation of what was suggested from the data-
base analysis: the deleterious effect of, and negative selection
against, long stretches of highly amyloidogenic residues. This
adds to the accumulating evidence that protein sequences
have evolved sequence and structural adaptations to prevent
aggregation (reviewed in Monsellier and Chiti (49)).
Existence of a ‘‘permissive window’’ for
aggregating stretches
Whereas the P3 and P4 variants of apoMb1-29 have high val-
ues of Sagg and correspondingly high values of kagg compared
to the wild-type peptide, the P1 and P2 variants have only
marginally lower values of Sagg (Table 1). The Zaggprof of the P1
variant is lower than 1.0 throughout the sequence (Fig. 1 A),
causing its Sagg value to be the lowest possible, that is 0
(Table 1). However, the kagg values of P1 and P2 apoMb1-29
are similar to that determined for the wild-type peptide
(Table 2), indicating that the dispersion of the amyloidogenic
residues from the center to the edges of the sequence and the
subsequent suppression of the central aggregating region does
not reduce dramatically aggregation. It therefore appears that
maintenance of an aggregating segment within a sequence
does not lead to severe consequences in terms of aggregation,
provided that the aggregation propensity of such segment is
not too marked.
In addition, it was shown that a delicate tradeoff between
positive and negative selections exists: the requirement for a
proper and stable fold acquired in a reasonable time on the
one hand, and the necessity to avoid aggregation on the other
hand, two parameters that cannot be optimized simultaneously
(50,51). Mutations decreasing the aggregation potential of an
aggregating segment within a normally folded protein gen-
erally results in a destabilization of the native structure (52).
These independent observations suggest that the sequence
segments with relatively high aggregation propensity existing
in globular proteins are indeed essential for the achievement
of a three-dimensional structure, and are easily tolerated be-
cause they do not represent a severe problem in aggregation.
Different strategies have been developed by natural evolu-
tion to counteract the aggregation of a protein, both by using
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dedicated cellular machineries, such as chaperones and quality
control mechanisms (53,54), and at the sequence level, such
as gatekeeper residues, negative design of the b-sheets, etc.
(49). This arsenal may be redundant, which could allow the
cell to deal with sequences containing short stretches of
aggregation-prone residues, necessary for a proper folding.
Overall, our data suggest the existence of a ‘‘permissive
window’’ for stretches of aggregation-prone residues: highly
aggregating stretches are prevented, but moderately aggregat-
ing ones are tolerated. This permissibility might be of funda-
mental importance in the evolutionary search of modiﬁed or
novel sequences, as it would guarantee a certain degree of
freedom in the search of novel biologically relevant sequences
with no signiﬁcant consequences on protein aggregation.
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